Remote monitoring for patients with implanted cardiac electrophysiology devices may finally be coming of age in the U.K. thanks to a review of these systems by the National Institute for Health and ...

Two remote monitoring tools for people diagnosed with heart failure have been approved by NICE for use in the NHS.

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

The UK public body has urged the use of the Manchester developed TriageHF Plus after research found it cut hospitalisations ...

agency NICE has concluded that Boston Scientific's HeartLogic and Medtronic's TriageHF diagnostics are "options for algorithm-based remote monitoring in people with cardiac implantable electronic ...

Heart failure mainly affects people over 65, with an average age at diagnosis of 77. Remote monitoring is the ability for a CIED to communicate wirelessly with a remote monitoring system. People who ...

Global Remote Patient Monitoring Market is estimated to be valued at $40B in 2023, expected to grow at CAGR of ~12% during the forecast period (2024 – 2030) ...

The NIM-Response® 3.0 and NIM-Neuro® 3.0 offer advanced nerve monitoring technology with an easy-to-use interface. NIM® systems monitor EMG activity from multiple mucles. If there is a change ...

Boost, GPx will refine the accuracy of its debut product, CardioID, the world's first implant and needle-free remote blood monitoring solution for heart failure patients ... Sony Corporation, Jana ...

Intraoperative NIM nerve monitoring systems enable surgeons to identify, confirm, and monitor motor nerve function to help reduce the risk of nerve damage during various procedures, including ENT ...

Medtronic (NYSE:MDT) said it has received European approval for its disposable continuous glucose monitor, the MidiMed 780G system with Simplera Sync sensor. The medical device maker said it was ...